News
Hosted on MSN4mon
What is Spravato, an FDA-approved First Standalone Esketamine-based Nasal Spray Monotherapy for Depression?However, the mechanism by which esketamine (the main ingredient in Spravato) exerts its antidepressant effect is still unknown. In studies done on mice, the drug appears to quickly improve the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results